Advanced Prostate Adenocarcinoma With Neuroendocrine Differentiation

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Advanced Prostate Adenocarcinoma With Neuroendocrine Differentiation trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1

NCT07080242

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

The objective of this study is to evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BL-M14D1 in Subjects with locally Advanced or Metastatic…

United States120 participantsStarted 2025-04-28

Treatment: BL-M14D1

All recent trials (8 shown)

Active — Not RecruitingPhase 2

NCT02893917

Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced P…

This randomized phase II trial studies how well olaparib with or without cediranib works in treating patients with castration-resistant prostate cancer that has…

United States90 participantsStarted 2017-08-11

Treatment: Cediranib, Olaparib

Active — Not RecruitingPhase 1

NCT04514484

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and…

This phase I trial investigates the side effects of cabozantinib and nivolumab in treating patients with cancer that may have spread from where it first started…

United States8 participantsStarted 2021-11-22

Treatment: Biospecimen Collection, Cabozantinib S-malate

Advanced Prostate Adenocarcinoma With Neuroendocrine Differentiation

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

All recent trials (8 shown)

Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced P…

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

All recent trials (8 shown)

Testing Two Oral Drugs Combination (Cediranib and Olaparib) Compared to a Single Drug (Olaparib) for Men With Advanced P…

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and…

A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours

PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership…

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain